Table 2 Comparison of Charlson comorbidity index scores of patients taking and not taking antiplatelet agents
Comorbidity | Taking antiplatelets (n = 61) | Not taking antiplatelets (n = 754) | p value | Total (n = 815) |
|---|---|---|---|---|
Acute myocardial infarction | 4 (6.6) | 7 (0.9) | < 0.01 | 11 (1.4) |
Congestive heart failure | 14 (23.0) | 73 (9.7) | < 0.01 | 87 (10.7) |
Peripheral vascular disease | 0 (0.0) | 2 (0.3) | 0.69 | 2 (0.3) |
Cerebral infarction | 14 (23.0) | 33 (4.4) | < 0.01 | 47 (5.8) |
Cerebral bleeding | 2 (3.3) | 13 (1.7) | 0.39 | 15 (1.8) |
Dementia | 5 (8.2) | 56 (7.4) | 0.83 | 61 (7.5) |
Pulmonary disease | 9 (14.8) | 55 (7.3) | 0.04 | 64 (7.9) |
Connective tissue disorder | 0 (0.0) | 0 (0.0) | 1.00 | 0 (0.0) |
Peptic ulcer | 0 (0.0) | 5 (0.7) | 0.52 | 5 (0.6) |
Mild to moderate liver disease | 0 (0.0) | 30 (4.0) | 0.11 | 30 (3.7) |
Diabetes | 12 (19.7) | 41 (5.4) | < 0.01 | 53 (6.5) |
Paraplegia | 0 (0.0) | 1 (0.1) | 0.78 | 1 (0.1) |
Renal disease | 5 (8.2) | 35 (4.6) | 0.22 | 40 (4.9) |
Diabetes with complications | 0 (0.0) | 2 (0.3) | 0.69 | 2 (0.3) |
Cancer | 13 (21.3) | 321 (42.6) | 0.01 | 334 (41.0) |
Leukemia | 0 (0.0) | 2 (0.3) | 0.69 | 2 (0.2) |
Malignant lymphoma | 0 (0.0) | 10 (1.3) | 0.37 | 10 (1.2) |
Severe liver disease | 0 (0.0) | 18 (2.4) | 0.22 | 18 (2.2) |
Metastatic cancer | 4 (6.6) | 74 (9.8) | 0.41 | 78 (9.6) |
HIV | 0 (0.0) | 0 (0.0) | 1.00 | 0 (0.0) |